Clinical Trial Update: Skin Barrier and Microbiome of CTCL Patients

View source ↗

Summary

The trial update reports on a study evaluating skin barrier function and the skin microbiome in patients with cutaneous T-cell lymphoma (CTCL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Snippet

Sponsor: Centre for Human Drug Research, Netherlands | Conditions: Lymphoma, T-Cell, Cutaneous | Status: COMPLETED